Nanocząstki o wysokiej zawartości boru jako potencjalne nośniki w terapii borowo-neutronowej^*

[1] Al-Madhoun A.S., Johnsamuel J., Barth R.F., Tjarks W., Eriksson S.: Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy. Cancer Res., 2004; 64: 6280–6286 Al-MadhounA.S. JohnsamuelJ. BarthR.F. TjarksW. ErikssonS. Evaluation of human thymidine kinase 1 substrates as new candidates for boron neutron capture therapy Cancer Res. 2004 64 6280 6286 10.1158/0008-5472.CAN-04-0197 Search in Google Scholar

[2] Archambeau J.O.: The effect of increasing exposures of the 10B(n,α)7Li reaction on the skin of man. Radiology, 1970; 94: 178–187 ArchambeauJ.O. The effect of increasing exposures of the 10B(n,α)7Li reaction on the skin of man Radiology 1970 94 178 187 Search in Google Scholar

[3] Barth R.F., Coderre J.A., Vicente M.G., Blue T.E.: Boron neutron capture therapy of cancer: Current status and future prospects. Clin. Cancer. Res., 2005; 11: 3987–4002 BarthR.F. CoderreJ.A. VicenteM.G. BlueT.E. Boron neutron capture therapy of cancer: Current status and future prospects Clin. Cancer. Res. 2005 11 3987 4002 10.1158/1078-0432.CCR-05-0035 Search in Google Scholar

[4] Barth R.F., Kabalka G.W., Yang W., Huo T., Nakkula R.J., Shaikh A.L., Haider S.A., Chandra S.: Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas. Appl. Radiat. Isot., 2014; 88: 38–42 BarthR.F. KabalkaG.W. YangW. HuoT. NakkulaR.J. ShaikhA.L. HaiderS.A. ChandraS. Evaluation of unnatural cyclic amino acids as boron delivery agents for treatment of melanomas and gliomas Appl. Radiat. Isot. 2014 88 38 42 10.1016/j.apradiso.2013.11.133 Search in Google Scholar

[5] Barth R.F., Mi P., Yang W.: Boron delivery agents for neutron capture therapy of cancer. Cancer Commun., 2018; 38: 35 BarthR.F. MiP. YangW. Boron delivery agents for neutron capture therapy of cancer Cancer Commun. 2018 38 35 10.1186/s40880-018-0299-7 Search in Google Scholar

[6] Barth R.F., Yang W., Nakkula R.J., Byun Y., Tjarks W., Wu L.C., Binns P.J., Riley K.J.: Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. Appl. Radiat. Isot., 2015; 106: 251–255 BarthR.F. YangW. NakkulaR.J. ByunY. TjarksW. WuL.C. BinnsP.J. RileyK.J. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors Appl. Radiat. Isot. 2015 106 251 255 10.1016/j.apradiso.2015.06.031 Search in Google Scholar

[7] Barth R.F., Yang W., Rotaru J.H., Moeschberger M.L., Joel D.D., Nawrocky M.M., Goodman J.H., Soloway A.H..: Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood–brain barrier disruption. Cancer Res., 1997; 57: 1129–1136 BarthR.F. YangW. RotaruJ.H. MoeschbergerM.L. JoelD.D. NawrockyM.M. GoodmanJ.H. SolowayA.H. Boron neutron capture therapy of brain tumors: Enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood–brain barrier disruption Cancer Res. 1997 57 1129 1136 10.1016/S0360-3016(00)00421-1 Search in Google Scholar

[8] Bertrand N., Wu J., Xu X., Kamaly N., Farokhzad O.C.: Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology. Adv. Drug Deliv. Rev. 2014; 66: 2–25 BertrandN. WuJ. XuX. KamalyN. FarokhzadO.C. Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology Adv. Drug Deliv. Rev 2014 66 2 25 10.1016/j.addr.2013.11.009421925424270007 Search in Google Scholar

[9] Bhimanapati G.R., Glavin N.R. Robinson J.A.: 2D boron nitride: Synthesis and applications. Semicond. Semimet., 2016; 95: 101–147 BhimanapatiG.R. GlavinN.R. RobinsonJ.A. 2D boron nitride: Synthesis and applications Semicond. Semimet. 2016 95 101 147 10.1016/bs.semsem.2016.04.004 Search in Google Scholar

[10] Bortolussi S., Bakeine J.G., Ballarini F., Bruschi P., Gadan M. A., Protti N., Stella S., Clerici A., Ferrari C., Cansolino L., Zonta C., Zonta A., Nano R., Altieri S.: Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours. Appl. Radiat. Isot., 2011; 69: 394–398 BortolussiS. BakeineJ.G. BallariniF. BruschiP. GadanM. A. ProttiN. StellaS. ClericiA. FerrariC. CansolinoL. ZontaC. ZontaA. NanoR. AltieriS. Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours Appl. Radiat. Isot. 2011 69 394 398 10.1016/j.apradiso.2010.11.01821145752 Search in Google Scholar

[11] Capuani S., Gili T., Bozzali M., Russo S., Porcari P., Cametti C., Muolo M., D’Amore E., Maraviglia B., Lazzarino G., Pastore F.S.: Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading. Appl. Radiat. Isot., 2009; 67: S34–S36 CapuaniS. GiliT. BozzaliM. RussoS. PorcariP. CamettiC. MuoloM. D’AmoreE. MaravigliaB. LazzarinoG. PastoreF.S. Boronophenylalanine uptake in C6 glioma model is dramatically increased by L-DOPA preloading Appl. Radiat. Isot. 2009 67 S34 S36 10.1016/j.apradiso.2009.03.01719375337 Search in Google Scholar

[12] Chen X., Wu P., Rousseas M., Okawa D., Gartner Z., Zettl A., Bertozzi C.R.: Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells. J. Am. Chem. Soc., 2009; 131: 890–891 ChenX. WuP. RousseasM. OkawaD. GartnerZ. ZettlA. BertozziC.R. Boron nitride nanotubes are noncytotoxic and can be functionalized for interaction with proteins and cells J. Am. Chem. Soc. 2009 131 890 891 10.1021/ja807334b265703819119844 Search in Google Scholar

[13] Ciofani G., Danti S., D’Alessandro D., Moscato S., Menciassi A.: Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assay. Biochem. Biophys. Res. Commun., 2010; 394: 405–411 CiofaniG. DantiS. D’AlessandroD. MoscatoS. MenciassiA. Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assay Biochem. Biophys. Res. Commun. 2010 394 405 411 10.1016/j.bbrc.2010.03.03520226164 Search in Google Scholar

[14] Ciofani G., Danti S., Genchi G.G., Mazzolai B., Mattoli V.: Boron nitride nanotubes: Biocompatibility and potential spill-over in nanomedicine. Small., 2013; 9: 1672–1685 CiofaniG. DantiS. GenchiG.G. MazzolaiB. MattoliV. Boron nitride nanotubes: Biocompatibility and potential spill-over in nanomedicine Small. 2013 9 1672 1685 10.1002/smll.20120131523423826 Search in Google Scholar

[15] Ciofani G., Raffa V., Menciassi., Cuschieri A.: Cytocompatibility, interactions, and uptake of polyethyleneimine-coated boron nitride nanotubes by living cells: Confirmation of their potential for biomedical applications. Biotechnol. Bioeng., 2008; 101: 850–858 CiofaniG. RaffaV. Menciassi. CuschieriA. Cytocompatibility, interactions, and uptake of polyethyleneimine-coated boron nitride nanotubes by living cells: Confirmation of their potential for biomedical applications Biotechnol. Bioeng. 2008 101 850 858 10.1002/bit.2195218512259 Search in Google Scholar

[16] Coderre J.A., Glass J.D., Fairchild R.G., Micca P.L., Fand I., Joel D.D.: Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. Cancer Res., 1990; 50: 138–141 CoderreJ.A. GlassJ.D. FairchildR.G. MiccaP.L. FandI. JoelD.D. Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma Cancer Res. 1990 50 138 141 Search in Google Scholar

[17] Cui D., Tian F., Ozkan C.S., Wang M., Gao H.: Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol. Lett., 2005; 155: 73–85 CuiD. TianF. OzkanC.S. WangM. GaoH. Effect of single wall carbon nanotubes on human HEK293 cells Toxicol. Lett. 2005 155 73 85 10.1016/j.toxlet.2004.08.01515585362 Search in Google Scholar

[18] Dahlström M., Capala J., Lindström P., Wasteson Å., Lindström A.: Accumulation of boron in human malignant glioma cells in vitro is cell type dependent. J. Neuro-Oncol., 2004; 68: 199–205 DahlströmM. CapalaJ. LindströmP. WastesonÅ. LindströmA. Accumulation of boron in human malignant glioma cells in vitro is cell type dependent J. Neuro-Oncol. 2004 68 199 205 10.1023/B:NEON.0000033489.54011.6b Search in Google Scholar

[19] Dobrzyński L.: Spowalnianie neutronów w moderatorze. W: Podstawy Fizyki Reaktorów Jądrowych, red.: L. Dobrzyński. Świerk 2013, 60–61 DobrzyńskiL. Spowalnianie neutronów w moderatorze W: Podstawy Fizyki Reaktorów Jądrowych red.: DobrzyńskiL. Świerk 2013 60 61 Search in Google Scholar

[20] Duong N.M., Glushkov E., Chernev A., Navikas V., Comtet J., Nguyen M.A., Toth M., Radenovic A., Tran T.T., Aharonovich I.: Facile production of hexagonal boron nitride nanoparticles by cryogenic exfoliation. Nano. Lett., 2019: 19: 5417–5422 DuongN.M. GlushkovE. ChernevA. NavikasV. ComtetJ. NguyenM.A. TothM. RadenovicA. TranT.T. AharonovichI. Facile production of hexagonal boron nitride nanoparticles by cryogenic exfoliation Nano. Lett. 2019 19 5417 5422 10.1021/acs.nanolett.9b0191331264881 Search in Google Scholar

[21] Feng B., Tomizawa K., Michiue H., Miyatake S., Han X.J., Fujimura A., Seno M., Kirihata M., Matsui H.: Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. Biomaterials, 2009; 30: 1746–1755 FengB. TomizawaK. MichiueH. MiyatakeS. HanX.J. FujimuraA. SenoM. KirihataM. MatsuiH. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His Biomaterials 2009 30 1746 1755 10.1016/j.biomaterials.2008.12.01019121537 Search in Google Scholar

[22] Ferreira T.H., Miranda M.C., Rocha Z., Leal A.S., Gomes D.A., Sousa E.M.: An assessment of the potential use of BNNTs for Boron Neutron Capture Therapy. Nanomaterials, 2017; 7: 82 FerreiraT.H. MirandaM.C. RochaZ. LealA.S. GomesD.A. SousaE.M. An assessment of the potential use of BNNTs for Boron Neutron Capture Therapy Nanomaterials 2017 7 82 10.3390/nano7040082540817428417903 Search in Google Scholar

[23] Gao Z., Horiguchi Y., Nakai K., Matsumura A., Suzuki M., Ono K., Nagasaki Y:. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects. Biomaterials, 2016; 104: 201–212 GaoZ. HoriguchiY. NakaiK. MatsumuraA. SuzukiM. OnoK. NagasakiY. Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects Biomaterials 2016 104 201 212 10.1016/j.biomaterials.2016.06.04627467416 Search in Google Scholar

[24] Gonzalez-Ortiz D., Salameh C., Bechelany M., Miele P.: Nanostructured boron nitride – based materials: Synthesis and applications. Mater. Today Adv., 2020; 8: 100107 Gonzalez-OrtizD. SalamehC. BechelanyM. MieleP. Nanostructured boron nitride – based materials: Synthesis and applications Mater. Today Adv. 2020 8 100107 10.1016/j.mtadv.2020.100107 Search in Google Scholar

[25] Goodman J.H., Yang W., Barth R.F., Gao Z., Boesel C.P., Staubus A.E., Gupta N., Gahbauer R.A., Adams D.M., Gibson C.R., Ferketich A.K., Moeschberger M.L., Soloway A.H., Carpenter D.E., Albertson B.J. i wsp.: Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery, 2000; 47: 608–621 GoodmanJ.H. YangW. BarthR.F. GaoZ. BoeselC.P. StaubusA.E. GuptaN. GahbauerR.A. AdamsD.M. GibsonC.R. FerketichA.K. MoeschbergerM.L. SolowayA.H. CarpenterD.E. AlbertsonB.J. i wsp. Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas Neurosurgery 2000 47 608 621 Search in Google Scholar

[26] Hatanaka H., Nakagawa Y.: Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys., 1994; 28: 1061–1066 HatanakaH. NakagawaY. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy Int. J. Radiat. Oncol. Biol. Phys. 1994 28 1061 1066 10.1016/0360-3016(94)90479-0 Search in Google Scholar

[27] Hiratsuka J., Kamitani N., Tanaka R., Tokiya R., Yoden E., Sakurai Y., Suzuki M.: Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT). J. Radiat. Res., 2020; 61: 945–951 HiratsukaJ. KamitaniN. TanakaR. TokiyaR. YodenE. SakuraiY. SuzukiM. Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT) J. Radiat. Res. 2020 61 945 951 10.1093/jrr/rraa068767469532990318 Search in Google Scholar

[28] Horváth L., Magrez A., Golberg D., Zhi C., Bando Y., Smajda R., Horváth E., Forró L., Schwaller B.: In vitro investigation of the cellular toxicity of boron nitride nanotubes. ACS Nano, 2011; 5: 3800–3810 HorváthL. MagrezA. GolbergD. ZhiC. BandoY. SmajdaR. HorváthE. ForróL. SchwallerB. In vitro investigation of the cellular toxicity of boron nitride nanotubes ACS Nano 2011 5 3800 3810 10.1021/nn200139h21495683 Search in Google Scholar

[29] Ichikawa H., Taniguchi E., Fujimoto T., Fukumori Y.: Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. Appl. Radiat. Isot., 2009; 67: S111–S114 IchikawaH. TaniguchiE. FujimotoT. FukumoriY. Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer Appl. Radiat. Isot. 2009 67 S111 S114 10.1016/j.apradiso.2009.03.02619376721 Search in Google Scholar

[30] Ishikawa Y., Shimizu Y., Sasaki T., Koshizaki N.: Boron carbide spherical particles encapsulated in graphite prepared by pulsed laser irradiation of boron in liquid medium. Appl. Phys. Lett., 2007; 91: 161110 IshikawaY. ShimizuY. SasakiT. KoshizakiN. Boron carbide spherical particles encapsulated in graphite prepared by pulsed laser irradiation of boron in liquid medium Appl. Phys. Lett. 2007 91 161110 10.1063/1.2799786 Search in Google Scholar

[31] Itoh T., Tamura K., Ueda H., Tanaka T., Sato K., Kuroda R., Aoki S.: Design and synthesis of boron containing monosaccharides by the hydroboration of D-glucal for use in boron neutron capture therapy (BNCT). Bioorg. Med. Chem., 2018; 26: 5922–5933 ItohT. TamuraK. UedaH. TanakaT. SatoK. KurodaR. AokiS. Design and synthesis of boron containing monosaccharides by the hydroboration of D-glucal for use in boron neutron capture therapy (BNCT) Bioorg. Med. Chem. 2018 26 5922 5933 10.1016/j.bmc.2018.10.04130420329 Search in Google Scholar

[32] Iwagami T., Ishikawa Y., Koshizaki N., Yamamoto N., Tanaka H., Masunaga S., Sakurai Y., Kato I., Iwai S., Suzuki M., Yura Y.: Boron carbide particle as a boron compound for Boron Neutron Capture Therapy. J. Nucl. Med. Radiat. Ther., 2014; 5: 2 IwagamiT. IshikawaY. KoshizakiN. YamamotoN. TanakaH. MasunagaS. SakuraiY. KatoI. IwaiS. SuzukiM. YuraY. Boron carbide particle as a boron compound for Boron Neutron Capture Therapy J. Nucl. Med. Radiat. Ther. 2014 5 2 Search in Google Scholar

[33] Kabalka G.W., Shaikh A.L., Barth R.F., Huo T., Yang W., Gordnier P.M., Chandra S.: Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy. Appl. Radiat. Isot., 2011; 69: 1778–1781 KabalkaG.W. ShaikhA.L. BarthR.F. HuoT. YangW. GordnierP.M. ChandraS. Boronated unnatural cyclic amino acids as potential delivery agents for neutron capture therapy Appl. Radiat. Isot. 2011 69 1778 1781 10.1016/j.apradiso.2011.03.035313578321481596 Search in Google Scholar

[34] Kabalka G.W., Yao M.L., Marepally S.R., Chandra S.: Biological evaluation of boronated unnatural amino acids as new boron carriers. Appl. Radiat. Isot., 2009; 67: S374–S379 KabalkaG.W. YaoM.L. MarepallyS.R. ChandraS. Biological evaluation of boronated unnatural amino acids as new boron carriers Appl. Radiat. Isot. 2009 67 S374 S379 10.1016/j.apradiso.2009.03.104286133319398346 Search in Google Scholar

[35] Kageji T., Nagahiro S., Mizobuchi Y., Matsuzaki K., Nakagawa Y., Kumada H.: Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment. J. Med. Invest., 2014; 61: 254–263 KagejiT. NagahiroS. MizobuchiY. MatsuzakiK. NakagawaY. KumadaH. Boron neutron capture therapy (BNCT) for newly-diagnosed glioblastoma: Comparison of clinical results obtained with BNCT and conventional treatment J. Med. Invest. 2014 61 254 263 10.2152/jmi.61.25425264042 Search in Google Scholar

[36] Kato I., Fujita Y., Maruhashi A., Kumada H., Ohmae M., Kirihata M., Imahori Y., Suzuki M., Sakrai Y., Sumi T., Iwai S., Nakazawa M., Murata I., Miyamaru H., Ono K.: Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl. Radiat. Isot., 2009; 67: S37–S42 KatoI. FujitaY. MaruhashiA. KumadaH. OhmaeM. KirihataM. ImahoriY. SuzukiM. SakraiY. SumiT. IwaiS. NakazawaM. MurataI. MiyamaruH. OnoK. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies Appl. Radiat. Isot. 2009 67 S37 S42 10.1016/j.apradiso.2009.03.10319409799 Search in Google Scholar

[37] Kato T., Hirose K., Tanaka H., Mitsumoto T., Motoyanagi T., Arai K., Harada T., Takeuchi A., Kato R., Yajima S., Takai Y.: Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center. Appl. Radiat. Isot., 2020; 156: 108961 KatoT. HiroseK. TanakaH. MitsumotoT. MotoyanagiT. AraiK. HaradaT. TakeuchiA. KatoR. YajimaS. TakaiY. Design and construction of an accelerator-based boron neutron capture therapy (AB-BNCT) facility with multiple treatment rooms at the Southern Tohoku BNCT Research Center Appl. Radiat. Isot. 2020 156 108961 10.1016/j.apradiso.2019.10896131683088 Search in Google Scholar

[38] Kaur M., Singh P., Singh K., Gaharwar U.S., Meena R., Kumar M., Nakagawa F., Wu S., Suzuki M., Nakamura H., Kumar A.: Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT). Mater. Lett., 2020; 259: 126832 KaurM. SinghP. SinghK. GaharwarU.S. MeenaR. KumarM. NakagawaF. WuS. SuzukiM. NakamuraH. KumarA. Boron nitride (10BN) a prospective material for treatment of cancer by boron neutron capture therapy (BNCT) Mater. Lett. 2020 259 126832 10.1016/j.matlet.2019.126832 Search in Google Scholar

[39] Kawabata S., Yang W., Barth R.F., Wu G., Huo T., Binns P.J., Riley K.J., Ongayi O., Gottumukkala V., Vicente M.G.: Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. J. Neuro-Oncol., 2011; 103: 175–185 KawabataS. YangW. BarthR.F. WuG. HuoT. BinnsP.J. RileyK.J. OngayiO. GottumukkalaV. VicenteM.G. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors J. Neuro-Oncol. 2011 103 175 185 10.1007/s11060-010-0376-5300508120848301 Search in Google Scholar

[40] Kimura Y., Ariyoshi Y., Shimahara M., Miyatake S., Kawabata S., Ono K., Suzuki M., Maruhashi A.: Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node. Appl. Radiat. Isot., 2009; 67: S47–S49 KimuraY. AriyoshiY. ShimaharaM. MiyatakeS. KawabataS. OnoK. SuzukiM. MaruhashiA. Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node Appl. Radiat. Isot. 2009 67 S47 S49 10.1016/j.apradiso.2009.03.01919395269 Search in Google Scholar

[41] Kiyanagi Y., Sakurai Y., Kumada H., Tanaka H.: Status of accelerator-based BNCT projects worldwide. AIP Conf. Proc., 2019; 2160: 050012 KiyanagiY. SakuraiY. KumadaH. TanakaH. Status of accelerator-based BNCT projects worldwide AIP Conf. Proc. 2019 2160 050012 10.1063/1.5127704 Search in Google Scholar

[42] Kullberg E.B., Wei Q., Capala J., Giusti V., Malmström P.U., Gedda L.: EGF-receptor targeted liposomes with boronatedacridine: Growth inhibition of cultured glioma cells after neutron irradiation. Int. J. Radiat. Biol., 2005; 81: 621–629 KullbergE.B. WeiQ. CapalaJ. GiustiV. MalmströmP.U. GeddaL. EGF-receptor targeted liposomes with boronatedacridine: Growth inhibition of cultured glioma cells after neutron irradiation Int. J. Radiat. Biol. 2005 81 621 629 10.1080/0955300050033213716298943 Search in Google Scholar

[43] Kumada H., Naito F., Hasegawa K., Kobayashi H., Kurihara T., Takada K., Onishi T., Sakurai H., Matsumura A., Sakae T.: Development of LINAC-based neutron source for Boron Neutron Capture Therapy in University of Tsukuba. Plasma Fusion Res., 2018; 13: 2406006 KumadaH. NaitoF. HasegawaK. KobayashiH. KuriharaT. TakadaK. OnishiT. SakuraiH. MatsumuraA. SakaeT. Development of LINAC-based neutron source for Boron Neutron Capture Therapy in University of Tsukuba Plasma Fusion Res. 2018 13 2406006 10.1585/pfr.13.2406006 Search in Google Scholar

[44] Lai C.H., Lin Y.C., Chou F.I., Liang C.F., Lin E.W., Chuang Y.J., Lin C.C.: Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy. Chem. Commun., 2012; 48: 612–614 LaiC.H. LinY.C. ChouF.I. LiangC.F. LinE.W. ChuangY.J. LinC.C. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy Chem. Commun. 2012 48 612 614 10.1039/C1CC14447B Search in Google Scholar

[45] Lam C.W., James J.T., McCluskey R., Hunter R.L.: Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol. Sci., 2004; 77: 126–134 LamC.W. JamesJ.T. McCluskeyR. HunterR.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation Toxicol. Sci. 2004 77 126 134 10.1093/toxsci/kfg24314514958 Search in Google Scholar

[46] Lee C.H., Zhang D., Yap Y.K.: Functionalization, dispersion, and cutting of boron nitride nanotubes in water. J. Phys. Chem. C, 2012; 116: 1798–1804 LeeC.H. ZhangD. YapY.K. Functionalization, dispersion, and cutting of boron nitride nanotubes in water J. Phys. Chem. C 2012 116 1798 1804 10.1021/jp2112999 Search in Google Scholar

[47] Luderer M.J., de la Puente P., Azab A.K.: Advancements in tumor targeting strategies for Boron Neutron Capture Therapy. Pharm. Res., 2015; 32: 2824–2836 LudererM.J. de la PuenteP. AzabA.K. Advancements in tumor targeting strategies for Boron Neutron Capture Therapy Pharm. Res. 2015 32 2824 2836 10.1007/s11095-015-1718-y Search in Google Scholar

[48] Luderer M.J., Muz B., Alhallak K., Sun J., Wasden K., Guenthner N., de la Puente P., Federico C., Azab A.K.: Thermal sensitive liposomes improve delivery of boronated agents for Boron Neutron Capture Therapy. Pharm. Res., 2019; 36: 144 LudererM.J. MuzB. AlhallakK. SunJ. WasdenK. GuenthnerN. de la PuenteP. FedericoC. AzabA.K. Thermal sensitive liposomes improve delivery of boronated agents for Boron Neutron Capture Therapy Pharm. Res. 2019 36 144 10.1007/s11095-019-2670-z Search in Google Scholar

[49] Masunaga S., Kasaoka S., Maruyama K., Nigg D., Sakurai Y., Nagata K., Suzuki M., Kinashi Y., Maruhashi A., Ono K.: The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10B (GB-10) as 10B-carriers for boron neutron capture therapy. Int. J. Radiat. Oncol. Biol. Phys., 2006; 66: 1515–1522 MasunagaS. KasaokaS. MaruyamaK. NiggD. SakuraiY. NagataK. SuzukiM. KinashiY. MaruhashiA. OnoK. The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-10B (GB-10) as 10B-carriers for boron neutron capture therapy Int. J. Radiat. Oncol. Biol. Phys. 2006 66 1515 1522 10.1016/j.ijrobp.2006.08.028 Search in Google Scholar

[50] Mattson M.P., Haddon R.C., Rao A.M.: Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth. J. Mol. Neurosci., 2000; 14: 175–182 MattsonM.P. HaddonR.C. RaoA.M. Molecular functionalization of carbon nanotubes and use as substrates for neuronal growth J. Mol. Neurosci. 2000 14 175 182 10.1385/JMN:14:3:175 Search in Google Scholar

[51] Mi P., Yanagie H., Dewi N., Yen H.C., Liu X., Suzuki M., Sakurai Y., Ono K., Takahashi H., Cabral H., Kataoka K., Nishiyama N.: Block co-polymer boron cluster conjugate for effective boron neutron capture therapy of solid tumors. J. Control. Release, 2017; 254: 1–9 MiP. YanagieH. DewiN. YenH.C. LiuX. SuzukiM. SakuraiY. OnoK. TakahashiH. CabralH. KataokaK. NishiyamaN. Block co-polymer boron cluster conjugate for effective boron neutron capture therapy of solid tumors J. Control. Release 2017 254 1 9 10.1016/j.jconrel.2017.03.036 Search in Google Scholar

[52] Michiue H., Sakurai Y., Kondo N., Kitamatsu M., Bin F., Nakajima K., Hirota Y., Kawabata S., Nishiki T., Ohmori I., Tomizawa K., Miyatake S., Ono K., Matsui H.: The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide. Biomaterials, 2014; 35: 3396–3405 MichiueH. SakuraiY. KondoN. KitamatsuM. BinF. NakajimaK. HirotaY. KawabataS. NishikiT. OhmoriI. TomizawaK. MiyatakeS. OnoK. MatsuiH. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide Biomaterials 2014 35 3396 3405 10.1016/j.biomaterials.2013.12.055 Search in Google Scholar

[53] Mirzaei H.R., Sahebkar A., Salehi R., Nahand J.S., Karimi E., Jaafari M.R., Mirzaei H.: Boron neutron capture therapy: Moving toward targeted cancer therapy. J. Cancer Res. Ther., 2016; 12: 520–525 MirzaeiH.R. SahebkarA. SalehiR. NahandJ.S. KarimiE. JaafariM.R. MirzaeiH. Boron neutron capture therapy: Moving toward targeted cancer therapy J. Cancer Res. Ther. 2016 12 520 525 10.4103/0973-1482.176167 Search in Google Scholar

[54] Mishima Y., Honda C., Ichihashi M., Obara H., Hiratsuka J., Fukuda H., Karashima H., Kobayashi T., Kanda K., Yoshino K.: Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound. Lancet, 1989; 2: 388–389 MishimaY. HondaC. IchihashiM. ObaraH. HiratsukaJ. FukudaH. KarashimaH. KobayashiT. KandaK. YoshinoK. Treatment of malignant melanoma by single thermal neutron capture therapy with melanoma-seeking 10B-compound Lancet 1989 2 388 389 10.1016/S0140-6736(89)90567-9 Search in Google Scholar

[55] Miyatake S.I., Kawabata S., Hiramatsu R., Kuroiwa T., Suzuki M., Ono K.: Boron Neutron Capture Therapy of malignant gliomas. Prog. Neurol. Surg., 2018; 32: 48–56 MiyatakeS.I. KawabataS. HiramatsuR. KuroiwaT. SuzukiM. OnoK. Boron Neutron Capture Therapy of malignant gliomas Prog. Neurol. Surg. 2018 32 48 56 10.1159/000469679 Search in Google Scholar

[56] Miyatake S.I., Kawabata S., Kajimoto Y., Aoki A., Yokoyama K., Yamada M., Kuroiwa T., Tsuji M., Imahori Y., Kirihata M., Sakurai Y., Masunaga S.I., Nagata K., Maruhashi A., Ono K.: Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages. J. Neurosurg., 2005; 103: 1000–1009 MiyatakeS.I. KawabataS. KajimotoY. AokiA. YokoyamaK. YamadaM. KuroiwaT. TsujiM. ImahoriY. KirihataM. SakuraiY. MasunagaS.I. NagataK. MaruhashiA. OnoK. Modified boron neutron capture therapy for malignant gliomas performed using epithermal neutron and two boron compounds with different accumulation mechanisms: An efficacy study based on findings on neuroimages J. Neurosurg. 2005 103 1000 1009 10.3171/jns.2005.103.6.100016381186 Search in Google Scholar

[57] Mortensen M.W., Sørensen P.G., Björkdahl O., Jensen M.R., Gundersen H.J., Bjørnholm T.: Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy. Appl. Radiat. Isot., 2006; 64: 315–324 MortensenM.W. SørensenP.G. BjörkdahlO. JensenM.R. GundersenH.J. BjørnholmT. Preparation and characterization of boron carbide nanoparticles for use as a novel agent in T cell-guided boron neutron capture therapy Appl. Radiat. Isot. 2006 64 315 324 10.1016/j.apradiso.2005.08.00316290943 Search in Google Scholar

[58] Moss R.L.: Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT). Appl. Radiat. Isot., 2014; 88: 2–11 MossR.L. Critical review, with an optimistic outlook, on Boron Neutron Capture Therapy (BNCT) Appl. Radiat. Isot. 2014 88 2 11 10.1016/j.apradiso.2013.11.10924355301 Search in Google Scholar

[59] Naito F.: Introduction to accelerators for boron neutron capture therapy. Ther. Radiol. Oncol., 2018; 2: 54 NaitoF. Introduction to accelerators for boron neutron capture therapy Ther. Radiol. Oncol. 2018 2 54 10.21037/tro.2018.10.11 Search in Google Scholar

[60] Nakagawa Y., Pooh K., Kobayashi T., Kageji T., Uyama S., Matsumura A., Kumada H.: Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams. J. Neuro-Oncol., 2003; 62: 87–99 NakagawaY. PoohK. KobayashiT. KagejiT. UyamaS. MatsumuraA. KumadaH. Clinical review of the Japanese experience with boron neutron capture therapy and a proposed strategy using epithermal neutron beams J. Neuro-Oncol. 2003 62 87 99 10.1007/BF0269993612749705 Search in Google Scholar

[61] Nakamura H., Koganei H., Miyoshi T., Sakurai Y., Ono K., Suzuki M.: Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT. Bioorg. Med. Chem. Lett., 2015; 25: 172–174 NakamuraH. KoganeiH. MiyoshiT. SakuraiY. OnoK. SuzukiM. Antitumor effect of boron nitride nanotubes in combination with thermal neutron irradiation on BNCT Bioorg. Med. Chem. Lett. 2015 25 172 174 10.1016/j.bmcl.2014.12.00525522821 Search in Google Scholar

[62] Nakamura S., Imamichi S., Masumoto K., Ito M., Wakita A., Okamoto H., Nishioka S., Iijima K., Kobayashi K., Abe Y., Igaki H., Kurita K., Nishio T., Masutani M., Itami J.: Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci., 2017; 93: 821–831 NakamuraS. ImamichiS. MasumotoK. ItoM. WakitaA. OkamotoH. NishiokaS. IijimaK. KobayashiK. AbeY. IgakiH. KuritaK. NishioT. MasutaniM. ItamiJ. Evaluation of radioactivity in the bodies of mice induced by neutron exposure from an epi-thermal neutron source of an accelerator-based boron neutron capture therapy system Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2017 93 821 831 10.2183/pjab.93.051579075929225308 Search in Google Scholar

[63] Nedunchezhian K., Aswath N., Thiruppathy M., Thirugnanamurthy S.: Boron Neutron Capture Therapy – A literature review. J. Clin. Diagn. Res., 2016; 10: ZE01–ZE04 NedunchezhianK. AswathN. ThiruppathyM. ThirugnanamurthyS. Boron Neutron Capture Therapy – A literature review J. Clin. Diagn. Res. 2016 10 ZE01 ZE04 10.7860/JCDR/2016/19890.9024529658828209015 Search in Google Scholar

[64] Nemoto H., Cai J., Asao N., Iwamoto S., Yamamoto Y.: Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake. J. Med. Chem., 1995; 38: 1673–1678 NemotoH. CaiJ. AsaoN. IwamotoS. YamamotoY. Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake J. Med. Chem. 1995 38 1673 1678 10.1021/jm00010a0127752191 Search in Google Scholar

[65] Petersen M.S., Petersen C.C., Agger R., Sutmuller M., Jensen M.R., Sørensen P.G., Mortensen M.W., Hansen T., Bjørnholm T., Gundersen H.J., Huiskamp R., Hokland M.: Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model. Anticancer Res., 2008; 28: 571–576 PetersenM.S. PetersenC.C. AggerR. SutmullerM. JensenM.R. SørensenP.G. MortensenM.W. HansenT. BjørnholmT. GundersenH.J. HuiskampR. HoklandM. Boron nanoparticles inhibit tumour growth by boron neutron capture therapy in the murine B16-OVA model Anticancer Res. 2008 28 571 576 Search in Google Scholar

[66] Radomski J., Rećko W.M., Ketling-Szemley M.: Własności azotku boru i metody jego otrzymywania. Wydawnictwa Przemysłu Maszynowego “WEMA”. Warszawa 1980 RadomskiJ. RećkoW.M. Ketling-SzemleyM. Własności azotku boru i metody jego otrzymywania Wydawnictwa Przemysłu Maszynowego “WEMA” Warszawa 1980 Search in Google Scholar

[67] Ryashentsev D.S., Belenkov E.A.: New BN polymorphs with two-dimensional structure. IOP Conf. Ser.: Mater. Sci. Eng., 2019; 537: 022060 RyashentsevD.S. BelenkovE.A. New BN polymorphs with two-dimensional structure IOP Conf. Ser.: Mater. Sci. Eng. 2019 537 022060 10.1088/1757-899X/537/2/022060 Search in Google Scholar

[68] Seki R., Wakisaka Y., Morimoto N., Takashina M., Koizumi M., Toki H., Fukuda M.: Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT). Radiol. Phys. Technol., 2017; 10: 387–408 SekiR. WakisakaY. MorimotoN. TakashinaM. KoizumiM. TokiH. FukudaM. Physics of epi-thermal boron neutron capture therapy (epi-thermal BNCT) Radiol. Phys. Technol. 2017 10 387 408 10.1007/s12194-017-0430-529159536 Search in Google Scholar

[69] Şen Ö., Emanet M., Çulha M.: One-step synthesis of hexagonal boron nitrides, their crystallinity and biodegradation. Front. Bioeng. Biotechnol., 2018; 6: 83 ŞenÖ. EmanetM. ÇulhaM. One-step synthesis of hexagonal boron nitrides, their crystallinity and biodegradation Front. Bioeng. Biotechnol. 2018 6 83 10.3389/fbioe.2018.00083602149929977891 Search in Google Scholar

[70] Shvedova A.A., Castranova V., Kisin E.R., Schwegler-Berry D., Murray A.R., Gandelsman V.Z., Maynard A., Baron P.: Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol. Environ. Health A, 2003; 66: 1909–1926 ShvedovaA.A. CastranovaV. KisinE.R. Schwegler-BerryD. MurrayA.R. GandelsmanV.Z. MaynardA. BaronP. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells J. Toxicol. Environ. Health A 2003 66 1909 1926 10.1080/71385395614514433 Search in Google Scholar

[71] Singh B., Kaur G., Singh P., Singh K. Kumar B., Vij A., Kumar M., Bala R., Meena R., Singh A., Thakur A., Kumar A.: Nanostructured boron nitride with high water dispersibility for Boron Neutron Capture Therapy. Sci. Rep., 2016; 6: 35535 SinghB. KaurG. SinghP. SinghK. KumarB. VijA. KumarM. BalaR. MeenaR. SinghA. ThakurA. KumarA. Nanostructured boron nitride with high water dispersibility for Boron Neutron Capture Therapy Sci. Rep. 2016 6 35535 10.1038/srep35535506968727759052 Search in Google Scholar

[72] Slatkin D.N.: A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit. Brain, 1991; 114: 1609–1629 SlatkinD.N. A history of boron neutron capture therapy of brain tumours. Postulation of a brain radiation dose tolerance limit Brain 1991 114 1609 1629 10.1093/brain/114.4.16091884169 Search in Google Scholar

[73] Suzuki M.: Boron neutron capture therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era. Int. J. Clin. Oncol., 2020; 25: 43–50 SuzukiM. Boron neutron capture therapy (BNCT): A unique role in radiotherapy with a view to entering the accelerator-based BNCT era Int. J. Clin. Oncol. 2020 25 43 50 10.1007/s10147-019-01480-431168726 Search in Google Scholar

[74] Suzuki M., Masunaga S.I., Kinashi Y., Takagaki M., Sakurai Y., Kobayashi T., Ono K.: The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice. Jpn. J. Cancer Res., 2000; 91: 1058–1064 SuzukiM. MasunagaS.I. KinashiY. TakagakiM. SakuraiY. KobayashiT. OnoK. The effects of boron neutron capture therapy on liver tumors and normal hepatocytes in mice Jpn. J. Cancer Res. 2000 91 1058 1064 10.1111/j.1349-7006.2000.tb00885.x592626811050478 Search in Google Scholar

[75] Tajes M., Ramos-Fernández E., Weng-Jiang X., Bosch-Morató M., Guivernau B., Eraso-Pichot A., Salvador B., Fernàndez-Busquets X., Roquer J., Muñoz F.J.: The blood-brain barrier: Structure, function and therapeutic approaches to cross it. Mol. Membr. Biol., 2014; 31: 152–167 TajesM. Ramos-FernándezE. Weng-JiangX. Bosch-MoratóM. GuivernauB. Eraso-PichotA. SalvadorB. Fernàndez-BusquetsX. RoquerJ. MuñozF.J. The blood-brain barrier: Structure, function and therapeutic approaches to cross it Mol. Membr. Biol. 2014 31 152 167 10.3109/09687688.2014.93746825046533 Search in Google Scholar

[76] Tsuji T., Yoshitomi H., Ishikawa Y., Koshizaki N., Suzuki M., Usukura J.: A method to selectively internalize submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent. J. Exp. Nanosci., 2020; 15: 1–11 TsujiT. YoshitomiH. IshikawaY. KoshizakiN. SuzukiM. UsukuraJ. A method to selectively internalize submicrometer boron carbide particles into cancer cells using surface transferrin conjugation for developing a new boron neutron capture therapy agent J. Exp. Nanosci. 2020 15 1 11 10.1080/17458080.2019.1692178 Search in Google Scholar

[77] Türkez H., Arslan M.E., Sönmez E., Geyikoğlu F., Açıkyıldız M., Tatar A.: Microarray assisted toxicological investigations of boron carbide nanoparticles on human primary alveolar epithelial cells. Chem. Biol. Interact., 2019; 300: 131–137 TürkezH. ArslanM.E. SönmezE. GeyikoğluF. AçıkyıldızM. TatarA. Microarray assisted toxicological investigations of boron carbide nanoparticles on human primary alveolar epithelial cells Chem. Biol. Interact. 2019 300 131 137 10.1016/j.cbi.2019.01.02130684454 Search in Google Scholar

[78] Vos M.J., Turowski B., Zanella F.E., Paquis P., Siefert A., Hideghéty K., Haselsberger K., Grochulla F., Postma T.J., Wittig A., Heimans J.J., Slotman B.J., Vandertop W.P., Sauerwein W.: Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961. Int. J. Radiat. Oncol. Biol. Phys., 2005; 61: 392–399 VosM.J. TurowskiB. ZanellaF.E. PaquisP. SiefertA. HideghétyK. HaselsbergerK. GrochullaF. PostmaT.J. WittigA. HeimansJ.J. SlotmanB.J. VandertopW.P. SauerweinW. Radiologic findings in patients treated with boron neutron capture therapy for glioblastoma multiforme within EORTC trial 11961 Int. J. Radiat. Oncol. Biol. Phys. 2005 61 392 399 10.1016/j.ijrobp.2004.06.008 Search in Google Scholar

[79] Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A., Webb T.R.: Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci., 2004; 77: 117–125 WarheitD.B. LaurenceB.R. ReedK.L. RoachD.H. ReynoldsG.A. WebbT.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats Toxicol. Sci. 2004 77 117 125 10.1093/toxsci/kfg228 Search in Google Scholar

[80] Weng Q., Wang B., Wang X., Hanagata N., Li X., Liu D., Wang X., Jiang X., Bando Y., Golberg D.: Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery. ACS Nano, 2014; 8: 6123–6130 WengQ. WangB. WangX. HanagataN. LiX. LiuD. WangX. JiangX. BandoY. GolbergD. Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery ACS Nano 2014 8 6123 6130 10.1021/nn5014808 Search in Google Scholar

[81] Wittig A., Sauerwein W.A., Coderre J.A.: Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro. Radiat. Res., 2000; 153: 173–180 WittigA. SauerweinW.A. CoderreJ.A. Mechanisms of transport of p-borono-phenylalanine through the cell membrane in vitro Radiat. Res. 2000 153 173 180 10.1667/0033-7587(2000)153[0173:MOTOPB]2.0.CO;2 Search in Google Scholar

[82] Wittig A., Stecher-Rasmussen F., Hilger R.A., Rassow J., Mauri P., Sauerwein W.: Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention. Appl. Radiat. Isot., 2011; 69: 1760–1764 WittigA. Stecher-RasmussenF. HilgerR.A. RassowJ. MauriP. SauerweinW. Sodium mercaptoundecahydro-closo-dodecaborate (BSH), a boron carrier that merits more attention Appl. Radiat. Isot. 2011 69 1760 1764 10.1016/j.apradiso.2011.02.046 Search in Google Scholar

[83] Wu G., Yang W., Barth R.F., Kawabata S., Swindall M., Bandyopadhyaya A.K., Tjarks W., Khorsandi B., Blue T.E., Ferketich A.K., Yang M., Christoforidis G.A., Sferra T.J., Binns P.J., Riley K.J. i wsp.: Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin. Cancer Res., 2007; 13: 1260–1268 WuG. YangW. BarthR.F. KawabataS. SwindallM. BandyopadhyayaA.K. TjarksW. KhorsandiB. BlueT.E. FerketichA.K. YangM. ChristoforidisG.A. SferraT.J. BinnsP.J. RileyK.J. i wsp. Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab Clin. Cancer Res. 2007 13 1260 1268 10.1158/1078-0432.CCR-06-2399 Search in Google Scholar

[84] Yanagië H., Tomita T., Kobayashi H., Fujii Y., Takahashi T., Hasumi K., Nariuchi H., Sekiguchi M.: Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br. J. Cancer, 1991; 63: 522–526 YanagiëH. TomitaT. KobayashiH. FujiiY. TakahashiT. HasumiK. NariuchiH. SekiguchiM. Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model Br. J. Cancer 1991 63 522 526 10.1038/bjc.1991.124 Search in Google Scholar

[85] Yang W., Barth R.F., Wu G., Tjarks W., Binns P., Riley K.: Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Appl. Radiat. Isot., 2009; 67: S328–S331 YangW. BarthR.F. WuG. TjarksW. BinnsP. RileyK. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents Appl. Radiat. Isot. 2009 67 S328 S331 10.1016/j.apradiso.2009.03.030 Search in Google Scholar

[86] Yang W., Wu G., Barth R.F., Swindall M.R., Bandyopadhyaya A.K., Tjarks W., Tordoff K., Moeschberger M., Sferra T.J., Binns P.J., Riley K.J., Ciesielski M.J., Fenstermaker R.A., Wikstrand C.J.: Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies. Clin. Cancer Res., 2008; 14: 883–891 YangW. WuG. BarthR.F. SwindallM.R. BandyopadhyayaA.K. TjarksW. TordoffK. MoeschbergerM. SferraT.J. BinnsP.J. RileyK.J. CiesielskiM.J. FenstermakerR.A. WikstrandC.J. Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies Clin. Cancer Res. 2008 14 883 891 10.1158/1078-0432.CCR-07-1968 Search in Google Scholar

[87] Yinghuai Z., Peng A.T., Carpenter K., Maguire J.A., Hosmane N.S., Takagaki M.: Substituted carborane-appended water-soluble single-wall carbon nanotubes: New approach to Boron Neutron Capture Therapy drug delivery. J. Am. Chem. Soc., 2005; 127: 9875–9880 YinghuaiZ. PengA.T. CarpenterK. MaguireJ.A. HosmaneN.S. TakagakiM. Substituted carborane-appended water-soluble single-wall carbon nanotubes: New approach to Boron Neutron Capture Therapy drug delivery J. Am. Chem. Soc. 2005 127 9875 9880 10.1021/ja0517116 Search in Google Scholar

[88] Yokoyama K., Miyatake S., Kajimoto Y., Kawabata S., Doi A., Yoshida T., Asano T., Kirihata M., Ono K., Kuroiwa T.: Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT. J. Neuro-Oncol., 2006; 78: 227–232 YokoyamaK. MiyatakeS. KajimotoY. KawabataS. DoiA. YoshidaT. AsanoT. KirihataM. OnoK. KuroiwaT. Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT J. Neuro-Oncol. 2006 78 227 232 10.1007/s11060-005-9099-416557351 Search in Google Scholar

[89] Zhuo J.C., Cai J., Soloway A.H., Barth R.F., Adams D.M., Ji W., Tjarks W.: Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors. J. Med. Chem., 1999; 42: 1282–1292 ZhuoJ.C. CaiJ. SolowayA.H. BarthR.F. AdamsD.M. JiW. TjarksW. Synthesis and biological evaluation of boron-containing polyamines as potential agents for neutron capture therapy of brain tumors J. Med. Chem. 1999 42 1282 1292 10.1021/jm980703f10197971 Search in Google Scholar